Cressey & Company LP was founded in 2007 and is based in Chicago, Illinois with an additional office in Nashville, Tennessee. Cressey & Company LP is a private equity firm specializing in buy-and-build, add-on acquisitions, and growth equity investments. It prefers to make control investments, but can also make minority investments in special situations. The firm prefers to invest in healthcare services, facilities, and provider businesses. It also invests in software, education, distribution, financial services and consumer products industries. The firm prefers to invest in the United States healthcare market. It prefers to invest between $10 million and $100 million with an average investment of $50 million in the companies with more than $10 million of EBITDA. The firm prefers to exit its investments between three years and seven years.

Criteria CaixaCorp is an investment group with holdings in financial and industrial companies. The company's core shareholder is "la Caixa"; it has been listed on the continuous market of the Spanish stock exchange since October 2007. Criteria has a firm commitment to international growth, active management of its portfolio within a framework of controlled risk, and boosting the growth, development and returns of the companies it invests in.The company is now a consolidated business reality and has set its sights on becoming a European benchmark for investment and development in companies which are leaders in their respective markets with proven capacity to create value and recurrent profitability. Criteria has a significant knowledge of the sectors in which it operates, a proven track record that affords a privileged position as an investment company, and experienced management teams. This is a goal towards which Criteria works day in day out and for which it is constantly identifying, analysing, studying and assessing new business and investment opportunities.

The Cross-Harbour (Holdings) Limited, an investment holding company, operates motoring schools, tunnels, and an electronic toll collection system in Hong Kong. It offers driver training lessons for individual learners; and fleet training for operators from various commercial and public organizations by operating a fleet of training vehicles, including private cars, light goods vehicles, medium goods vehicles, motorcycles, buses, skid cars, and articulated vehicles. The company also operates the Western Harbour Tunnel located at West Kowloon reclamation area; and manages the Cross-Harbour Tunnel at Hunghom. In addition, it provides electronic toll clearing facilities in Hong Kong for 11 toll roads and tunnels; and global positioning system service that offers fleet management service to corporate customers, as well as develops a data exchange platform, On-Board Trucker Information System.

Crosspoint Venture Partners was founded in 1970 and is based in Woodside, California. Crosspoint Venture Partners is no longer investing. It is a venture capital firm specializes in investments in early stage companies. The firm prefers to invest in companies engaged in e-business services; and software and broadband infrastructure industries. It invests in companies based in the Western United States. The firm invests up to $40 million per project and can also provide up to an additional $10 million in follow-on financings. It takes a board seat and prefers an equity participation of 20 percent or more in its portfolio companies.

Croudace has been operating as a building company since 1945, from its headquarters in Caterham, Surrey. It continues to expand its areas of operation and the number of homes built and has earned a reputation for providing quality new housing throughout the South East of England. The Croudace Homes Group comprises Croudace Homes Ltd., which develops private housing schemes, Portland Homes Plc, a niche developer based in south-east London, Croudace Homes in Partnership Ltd., which contracts to build affordable housing and Croudace Strategic Ltd., which secures and promotes a wide range of sites for mainly housing development.

Cruttenden Partners is trying to root the evil out of money. The investment firm says it invests in companies that "help create a better world." It targets companies with strong management teams and offers services, such as financing, structuring, exiting, equity optimization. With a focus on early and late-stage investments, Cruttenden Partners' portfolio includes holdings in the financial, biomedical, and technology industries, such as SRS Sound Design (audio electronics), eGoose (financial advisory products for online traders), and PRISMedical Corporation (fluid therapies).

Cushman & Wakefield Sonnenblick Goldman is a global leader in real estate financial services, providing highly specialized debt structuring, debt and equity placement, hospitality financing and sales, note sales and associated advisory services. As a premier real estate investment banking firm, Cushman & Wakefield specialize in providing integrated capital solutions for all asset classes and are also a recognized industry leader in the financing and sale of hospitality and resort properties.By drawing on our integrated full service global platform C&WSG are able to assess our clients' current property operations and, at the same time, develop repositioning strategies that enhance asset value and maximize appeal to capital sources. With C&WSG focus on both the debt and equity markets, C&WSG clients the depth of insight and expertise needed to deliver creative, customized structuring solutions drawing from both traditional and non-traditional capital sources in a rapidly changing marketplace. Understanding the entire capital stack from equity and preferred equity to permanent, bridge, mezzanine and construction loans, C&WSG finance specialists tailor solutions to achieve optimal proceeds on the most attractive terms. From the conventional to cutting edge innovations, C&WSG long-standing record is unrivalled.

Founded in 1981 as Citicorp's European private equity arm, CVC carried out its own buyout in 1993 and is now owned by its management. It has about 20 offices around the world. CVC Capital Partners is in the business of making other businesses its business. The private equity investor specializes in buyouts of firms in the UK, the US, Western Europe, Asia, and Australia. Its portfolio of more than 50 companies consists mainly of retail, manufacturing, and service firms. Holdings include UK department store chain Debenhams, US-based luggage maker Samsonite, and Japan-based restaurant chain operator Skylark. It acquired a 47.5% stake in Pilot Travel Centers (now Pilot Flying J) in 2008.

De Novo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by De Novo investment success in selected medical device and biotechnology companies.With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. De Novo invest in all stages of enterprise development and growth – from early stage to late stage. De Novo unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.Eight exits have occurred in DNV I -- four IPOs: Favrille (NASDAQ: FVRL), Fox Hollow Technologies (NASDAQ: EVVV), Renovis (NASDAQ: RNVS), and SenoRx (NASDAQ: SENO) and four acquisitions: CryoVascular Systems (Boston Scientific), TriVascular (Boston Scientific), LuMend (Johnson and Johnson) and Microvention (Terumo). DNV II has had one exit to date – Hansen Medical (NASDAQ: HNSN).

Delphi Ventures was founded in 1988 and is based in Menlo Park, California. Delphi Ventures is a venture capital firm specializing in seed early stage, and PIPE investments. The firm seeks to invest in healthcare companies with a focus on medical devices and biotechnology. Within medical devices, it invests in cardiovascular medicine, orthopedics, gynecology, minimally invasive surgery, urology, neurovascular medicine, and next-generation diagnostics. Within biotechnology, the firm typically invests after a company has either generated early human clinical data or completed preclinical efficacy and toxicity studies. It prefers to invest in companies that are discovering new ways to treat life-threatening diseases and designing new devices to make surgery less traumatic and treatments more precise. The firm primarily invests between $500,000 million and $12 million.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.